Negative regulators of angiogenesis: important targets for treatment of exudative AMD.
Negative regulators of angiogenesis: important targets for treatment of exudative AMD.
复制标题
DOI:
10.1042/cs20170066
复制
发表时间:
2017-08-01
期刊:
影响因子:
--
通讯作者:
Sheibani N
中科院分区:
文献类型:
--
作者:
Farnoodian M;Wang S;Dietz J;Nickells RW;Sorenson CM;Sheibani N
Angiogenesis contributes to pathogenesis of many diseases including exudative age-related macular degeneration (AMD). It is normally kept in check by a tightly balanced production of pro- and anti-angiogenic factors. The up-regulation of the proangiogenic factor, vascular endothelial growth factor, is intimately linked to the pathogenesis of exudative AMD, and its antagonism has been effectively targeted for treatment. However, very little is known about potential changes in expression of antiangiogenic factors and the role they play in choroidal vascular homeostasis and neovascularization associated with AMD. Here we will discuss the important role of thrombospondins and pigment epithelium derived factor, two major endogenous inhibitors of angiogenesis, in retinal and choroidal vascular homeostasis and their potential alterations during AMD and choroidal neovascularization. We will review the cell autonomous function of these proteins in retinal and choroidal vascular cells. We will also discuss the potential targeting of these molecules and use of their mimetic peptides for therapeutic development for exudative AMD.